Latest News

National News

AstraZeneca trial, illness link 'unlikely'

The adverse events that led to a pause in trials evaluating AstraZeneca Plc's COVID-19 vaccine candidate may not have been associated with the vaccine itself, according to a document outlining participant information that was posted online by the Oxford University.
If you have information on something happening near you or wish to contact the newroom use this link